{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:12:58Z","timestamp":1791490378022,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Human Ebola virus (EBOV) outbreaks caused by persistent EBOV infection raises questions on the role of zoonotic spillover in filovirus epidemiology. To characterise filovirus zoonotic exposure, we collected cross-sectional serum samples from bushmeat hunters (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009498) in Macenta Prefecture Guinea, adjacent to the index site of the 2013 EBOV-Makona spillover event. We identified distinct immune signatures (20\/498, 4.0%) to multiple EBOV antigens (GP, NP, VP40) using stepwise ELISA and Western blot analysis and, live EBOV neutralisation (5\/20; 25%). Using comparative serological data from PCR-confirmed survivors of the 2013-2016 EBOV outbreak, we demonstrated that most signatures (15\/20) were not plausibly explained by prior EBOV-Makona exposure. Subsequent data-driven modelling of EBOV immunological outcomes to remote-sensing environmental data also revealed consistent associations with intact closed canopy forest. Together our findings suggest exposure to other closely related filoviruses prior to the 2013-2016 West Africa epidemic and highlight future surveillance priorities.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-48587-5","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T13:01:57Z","timestamp":1715864517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea"],"prefix":"10.1038","volume":"15","author":[{"given":"Joseph","family":"Akoi Bor\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph W. S.","family":"Timothy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Tipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifono","family":"Kekoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yper","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5169-9437","authenticated-orcid":false,"given":"Grace","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5026-431X","authenticated-orcid":false,"given":"Stephanie","family":"Longet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Fornace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millimono S.","family":"Lucien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Katarina","family":"Fehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice K.","family":"Koivogui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si\u2019Ana A.","family":"Coggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u2019 Faly","family":"Magassouba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7857-937X","authenticated-orcid":false,"given":"Thomas","family":"Strecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6124-4103","authenticated-orcid":false,"given":"Jeremy","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kader","family":"Konde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7026-7187","authenticated-orcid":false,"given":"Miles W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"key":"48587_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","volume":"393","author":"D Malvy","year":"2019","unstructured":"Malvy, D., McElroy, A. K., de Clerck, H., Gunther, S. & van Griensven, J. Ebola virus disease. Lancet 393, 936\u2013948 (2019).","journal-title":"Lancet"},{"key":"48587_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1473-3099(17)30111-1","volume":"17","author":"JR Glynn","year":"2017","unstructured":"Glynn, J. R. et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect. Dis. 17, 645\u2013653 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"48587_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.micinf.2005.04.006","volume":"7","author":"X Pourrut","year":"2005","unstructured":"Pourrut, X. et al. The natural history of Ebola virus in Africa. Microbes Infect. 7, 1005\u20131014 (2005).","journal-title":"Microbes Infect."},{"key":"48587_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71226-0","volume":"10","author":"LK Koch","year":"2020","unstructured":"Koch, L. K., Cunze, S., Kochmann, J. & Klimpel, S. Bats as putative Zaire ebolavirus reservoir hosts and their habitat suitability in Africa. Sci. Rep. 10, 14268 (2020).","journal-title":"Sci. Rep."},{"key":"48587_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3389\/fimmu.2020.00026","volume":"11","author":"A Banerjee","year":"2020","unstructured":"Banerjee, A. et al. Novel Insights Into Immune Systems of Bats. Front Immunol. 11, 26 (2020).","journal-title":"Front Immunol."},{"key":"48587_CR6","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41564-018-0227-2","volume":"3","author":"T Goldstein","year":"2018","unstructured":"Goldstein, T. et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat. Microbiol. 3, 1084\u20131089 (2018).","journal-title":"Nat. Microbiol."},{"key":"48587_CR7","doi-asserted-by":"publisher","first-page":"20160297","DOI":"10.1098\/rstb.2016.0297","volume":"372","author":"CE Coltart","year":"2017","unstructured":"Coltart, C. E., Lindsey, B., Ghinai, I., Johnson, A. M. & Heymann, D. L. The Ebola outbreak, 2013-2016: old lessons for new epidemics. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372, 20160297 (2017).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"48587_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1473-3099(18)30791-6","volume":"19","author":"JWS Timothy","year":"2019","unstructured":"Timothy, J. W. S. et al. Early transmission and case fatality of Ebola virus at the index site of the 2013-16 west African Ebola outbreak: a cross-sectional seroprevalence survey. Lancet Infect. Dis. 19, 429\u2013438 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"48587_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.15252\/emmm.201404792","volume":"7","author":"A Mari Saez","year":"2015","unstructured":"Mari Saez, A. et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol. Med. 7, 17\u201323 (2015).","journal-title":"EMBO Mol. Med."},{"key":"48587_CR10","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3201\/eid2509.190581","volume":"25","author":"LS Karan","year":"2019","unstructured":"Karan, L. S. et al. Bombali Virus in Mops condylurus Bats, Guinea. Emerg. Infect. Dis. 25, 1774\u20131775 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"48587_CR11","doi-asserted-by":"publisher","first-page":"e1002877","DOI":"10.1371\/journal.ppat.1002877","volume":"8","author":"BR Amman","year":"2012","unstructured":"Amman, B. R. et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 8, e1002877 (2012).","journal-title":"PLoS Pathog."},{"key":"48587_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14327-8","volume":"11","author":"BR Amman","year":"2020","unstructured":"Amman, B. R. et al. Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa. Nat. Commun. 11, 510 (2020).","journal-title":"Nat. Commun."},{"key":"48587_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","volume":"597","author":"AK Keita","year":"2021","unstructured":"Keita, A. K. et al. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks. Nature 597, 539\u2013543 (2021).","journal-title":"Nature"},{"key":"48587_CR14","doi-asserted-by":"publisher","first-page":"e005783","DOI":"10.1136\/bmjgh-2021-005783","volume":"6","author":"J Fairhead","year":"2021","unstructured":"Fairhead, J., Leach, M. & Millimouno, D. Spillover or endemic? Reconsidering the origins of Ebola virus disease outbreaks by revisiting local accounts in light of new evidence from Guinea. BMJ Glob. Health 6, e005783 (2021).","journal-title":"BMJ Glob. Health"},{"key":"48587_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.133","volume":"4","author":"H Bower","year":"2017","unstructured":"Bower, H. & Glynn, J. R. A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection. Sci. Data. 4, 160133 (2017).","journal-title":"Sci. Data."},{"key":"48587_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S1473-3099(17)30110-X","volume":"17","author":"JH Kuhn","year":"2017","unstructured":"Kuhn, J. H. & Bavari, S. Asymptomatic Ebola virus infections-myth or reality? Lancet Infect. Dis. 17, 570\u2013571 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"48587_CR17","doi-asserted-by":"publisher","first-page":"e1175","DOI":"10.1371\/journal.pntd.0001175","volume":"5","author":"A Macneil","year":"2011","unstructured":"Macneil, A., Reed, Z. & Rollin, P. E. Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl. Trop. Dis. 5, e1175 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48587_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S1473-3099(20)30736-2","volume":"21","author":"R Thom","year":"2021","unstructured":"Thom, R. et al. Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study. Lancet Infect. Dis. 21, 507\u2013516 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"48587_CR19","doi-asserted-by":"publisher","first-page":"e676","DOI":"10.1016\/S2666-5247(21)00170-1","volume":"2","author":"MSK Diallo","year":"2021","unstructured":"Diallo, M. S. K. et al. Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study. Lancet Microbe 2, e676\u2013e84 (2021).","journal-title":"Lancet Microbe"},{"key":"48587_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/infdis\/jix584","volume":"217","author":"AW Rimoin","year":"2018","unstructured":"Rimoin, A. W. et al. Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection. J. Infect. Dis. 217, 223\u2013231 (2018).","journal-title":"J. Infect. Dis."},{"key":"48587_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.envsci.2021.05.025","volume":"124","author":"CS Peros","year":"2021","unstructured":"Peros, C. S., Dasgupta, R., Kumar, P. & Johnson, B. A. Bushmeat, wet markets, and the risks of pandemics: Exploring the nexus through systematic review of scientific disclosures. Environ. Sci. Policy 124, 1\u201311 (2021).","journal-title":"Environ. Sci. Policy"},{"key":"48587_CR22","doi-asserted-by":"publisher","first-page":"e0007654","DOI":"10.1371\/journal.pntd.0007654","volume":"13","author":"PJ Halfmann","year":"2019","unstructured":"Halfmann, P. J. et al. Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: A cross-sectional study. PLoS Negl. Trop. Dis. 13, e0007654 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48587_CR23","doi-asserted-by":"crossref","unstructured":"Fairhead J. Understanding Social Resistance to the Ebola Response in the Forest Region of the Republic of Guinea: An Anthropological Perspective: Cambridge University Press; 7-31 p. (2016)","DOI":"10.1017\/asr.2016.87"},{"key":"48587_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/infdis\/jiy499","volume":"219","author":"NA Hoff","year":"2019","unstructured":"Hoff, N. A. et al. Serologic Markers for Ebolavirus Among Healthcare Workers in the Democratic Republic of the Congo. J. Infect. Dis. 219, 517\u2013525 (2019).","journal-title":"J. Infect. Dis."},{"key":"48587_CR25","doi-asserted-by":"publisher","first-page":"e0005087","DOI":"10.1371\/journal.pntd.0005087","volume":"10","author":"ET Richardson","year":"2016","unstructured":"Richardson, E. T. et al. Minimally Symptomatic Infection in an Ebola \u2018Hotspot\u2019: A Cross-Sectional Serosurvey. PLoS Negl. Trop. Dis. 10, e0005087 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48587_CR26","doi-asserted-by":"publisher","first-page":"20160308","DOI":"10.1098\/rstb.2016.0308","volume":"372","author":"T Garske","year":"2017","unstructured":"Garske, T. et al. Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016. Philos. Trans. R. Soc. Lond. B Biol. Sci. 372, 20160308 (2017).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"48587_CR27","doi-asserted-by":"publisher","first-page":"e0007428","DOI":"10.1371\/journal.pntd.0007428","volume":"13","author":"EE Glennon","year":"2019","unstructured":"Glennon, E. E., Jephcott, F. L., Restif, O. & Wood, J. L. N. Estimating undetected Ebola spillovers. PLoS Negl. Trop. Dis. 13, e0007428 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48587_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42522-020-00028-1","volume":"2","author":"T Goldstein","year":"2020","unstructured":"Goldstein, T. et al. Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak. One Health Outlook 2, 21 (2020).","journal-title":"One Health Outlook"},{"key":"48587_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","volume":"164","author":"AI Flyak","year":"2016","unstructured":"Flyak, A. I. et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell 164, 392\u2013405 (2016).","journal-title":"Cell"},{"key":"48587_CR30","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/infdis\/jiy453","volume":"218","author":"MS Bramble","year":"2018","unstructured":"Bramble, M. S. et al. Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors. J. Infect. Dis. 218, 1929\u20131936 (2018).","journal-title":"J. Infect. Dis."},{"key":"48587_CR31","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1128\/CVI.00107-16","volume":"23","author":"M Natesan","year":"2016","unstructured":"Natesan, M. et al. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses. Clin. Vaccin. Immunol. 23, 717\u2013724 (2016).","journal-title":"Clin. Vaccin. Immunol."},{"key":"48587_CR32","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","volume":"160","author":"T Hashiguchi","year":"2015","unstructured":"Hashiguchi, T. et al. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160, 904\u2013912 (2015).","journal-title":"Cell"},{"key":"48587_CR33","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrmicro.2017.45","volume":"15","author":"RK Plowright","year":"2017","unstructured":"Plowright, R. K. et al. Pathways to zoonotic spillover. Nat. Rev. Microbiol. 15, 502\u2013510 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"48587_CR34","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1016\/j.vaccine.2019.09.009","volume":"37","author":"RJ Noad","year":"2019","unstructured":"Noad, R. J. et al. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments. Vaccine 37, 6241\u20136247 (2019).","journal-title":"Vaccine"},{"key":"48587_CR35","unstructured":"watch Gf. TREE COVER LOSS IN MACENTA, NZ\u00c9R\u00c9KOR\u00c9, GUINEA 2023 [Available from: https:\/\/www.globalforestwatch.org\/map\/country\/GIN\/8\/4\/?mainMap=eyJzaG93QW5hbHlzaXMiOnRydWV9&map=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&mapMenu=eyJtZW51U2VjdGlvbiI6ImRhdGFzZXRzIiwiZGF0YXNldENhdGVnb3J5IjoiZm9yZXN0Q2hhbmdlIiwic2VhcmNoIjoibWFjZW50YSJ9&mapPrompts=eyJvcGVuIjp0cnVlLCJzdGVwc0tleSI6InJlY2VudEltYWdlcnkifQ%3D%3D]."},{"key":"48587_CR36","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/infdis\/jiv565","volume":"213","author":"SD Dowall","year":"2016","unstructured":"Dowall, S. D. et al. Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection. J. Infect. Dis. 213, 1124\u20131133 (2016).","journal-title":"J. Infect. Dis."},{"key":"48587_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3201\/eid2804.212037","volume":"28","author":"ED Laing","year":"2022","unstructured":"Laing, E. D. et al. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers. Emerg. Infect. Dis. 28, 828\u2013832 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"48587_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijid.2016.11.272","volume":"53","author":"E Laing","year":"2016","unstructured":"Laing, E., Yan, L., Sterling, S. & Broder, C. A Luminex-based multiplex assay for the simultaneous detection of glycoprotein specific antibodies to ebolaviruses, marburgviruses, and henipaviruses. Int. J. Infect. Dis. 53, 108\u2013109 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"48587_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-59745-554-1_2","volume":"525","author":"YP Chan","year":"2009","unstructured":"Chan, Y. P., Yan, L., Feng, Y. R. & Broder, C. C. Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery. Methods Mol. Biol. 525, 31\u201358 (2009).","journal-title":"Methods Mol. Biol."},{"key":"48587_CR40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-0716-3283-3_3","volume":"2682","author":"L Yan","year":"2023","unstructured":"Yan, L. et al. Recombinant Soluble Henipavirus Glycoprotein Preparation. Methods Mol. Biol. 2682, 33\u201358 (2023).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48587-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48587-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T13:04:41Z","timestamp":1715864681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48587-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["48587"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-48587-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1347502\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4171"}}